Rennova Health, Inc. announced that it has entered into a Securities Purchase Agreement with certain existing institutional investors for a private placement of 1,100 shares of Series O Convertible Redeemable Preferred Stock at a price of $909.090909 each share for gross proceeds of $1,000,000 on September 7, 2021. Each share of the series O preferred stock is convertible into shares of the company’s common stock. The company will receive the funding in two tranches of 550 shares each.